Hum Fertil (camb) 24:276283
We propose that the effects of cumulative loss of surface receptor with fast-internalizing, slow-recycling, lysosome-targeting agonists, along with increases in -arrestin-induced desensitization, become more apparent with time, eventually overriding any positive effects associated with noncanonical signaling
This review summarizes current knowledge on the prevalence, etiology, and risk factors for antipsychotic-induced weight gain (AIWG), and evidence for interventions, including special considerations
What side effects might I experience
these medications are not reviewed or approved by the FDA for safety or effectiveness
A growing number of people are exploring GLP-1 medications for weight loss or as part of a broader effort to improve metabolic health, stabilize energy, and prevent long-term issues like diabetes or cardiovascular disease